{"id":"patent-clopidogrel","safety":{"commonSideEffects":[{"rate":"3-5","effect":"Bleeding"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"2-5","effect":"Diarrhea"},{"rate":"1-3","effect":"Rash"},{"rate":"<0.1","effect":"Thrombotic thrombocytopenic purpura (TTP)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clopidogrel is a thienopyridine prodrug that requires hepatic metabolism to its active form. The active metabolite irreversibly binds to the P2Y12 receptor on platelet surfaces, preventing ADP-induced platelet activation and aggregation. This antiplatelet effect reduces thrombotic events in patients at risk of cardiovascular complications.","oneSentence":"Clopidogrel inhibits platelet aggregation by blocking the P2Y12 adenosine diphosphate receptor on platelets.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:59:54.933Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction)"},{"name":"ST-elevation myocardial infarction"},{"name":"Peripheral arterial disease"},{"name":"Ischemic stroke or transient ischemic attack"},{"name":"Secondary prevention of atherothrombotic events"}]},"trialDetails":[{"nctId":"NCT07495969","phase":"NA","title":"Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion（REPAIR）","status":"NOT_YET_RECRUITING","sponsor":"Feng Gao","startDate":"2026-04-01","conditions":"Symptomatic Non-acute Intracranial Artery Occlusion, Ischemic Stroke","enrollment":286},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT07384702","phase":"PHASE2","title":"Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia","status":"NOT_YET_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2026-06","conditions":"Bacteremia Due to Staphylococcus Aureus","enrollment":230},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT00508924","phase":"PHASE2","title":"Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2005-08","conditions":"Coronary Artery Disease, Angina, Unstable","enrollment":140},{"nctId":"NCT07275749","phase":"PHASE3","title":"Acetyl-leucine in Post-stroke Ataxia","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT07265466","phase":"PHASE1","title":"to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban","status":"RECRUITING","sponsor":"Onconic Therapeutics Inc.","startDate":"2025-11-17","conditions":"Drug Drug Interaction (DDI)","enrollment":96},{"nctId":"NCT05752916","phase":"PHASE4","title":"Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-06-02","conditions":"Acute Ischemic Stroke","enrollment":570},{"nctId":"NCT06857045","phase":"NA","title":"Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation","status":"WITHDRAWN","sponsor":"Sino Medical Sciences Technology Inc.","startDate":"2024-07-09","conditions":"Intracranial Arteriosclerosis, Intracranial Artery Stenosis, Drug-Eluting Stents","enrollment":""},{"nctId":"NCT06714526","phase":"NA","title":"Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-10-07","conditions":"Intracranial Atherosclerosis","enrollment":100},{"nctId":"NCT03378934","phase":"PHASE4","title":"Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2018-09-26","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":64},{"nctId":"NCT06954155","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-30","conditions":"Stroke","enrollment":330},{"nctId":"NCT07180472","phase":"PHASE4","title":"Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Chengdu Medical College","startDate":"2025-09-20","conditions":"Cerebral Small Vessel Disease","enrollment":632},{"nctId":"NCT06591377","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-10","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06358313","phase":"PHASE3","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Moderate and Moderate-to-severe Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT06591338","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06360120","phase":"PHASE3","title":"Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT07095790","phase":"PHASE4","title":"Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2025-08-30","conditions":"Mild Stroke","enrollment":580},{"nctId":"NCT03430661","phase":"PHASE1","title":"A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2018-01-24","conditions":"Healthy","enrollment":77},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT03496506","phase":"PHASE1","title":"A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects","status":"COMPLETED","sponsor":"Actelion","startDate":"2018-03-05","conditions":"Healthy Subjects","enrollment":22},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT05952206","phase":"PHASE3","title":"Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy","status":"RECRUITING","sponsor":"iVascular S.L.U.","startDate":"2023-10-13","conditions":"Coronary Artery Disease","enrollment":2312},{"nctId":"NCT06873321","phase":"PHASE4","title":"VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization","status":"RECRUITING","sponsor":"Science Valley Research Institute","startDate":"2024-02-24","conditions":"Peripheral Arterial Disease, Venous Thormboembolism, Cardiovascular Diseases","enrollment":100},{"nctId":"NCT05353140","phase":"NA","title":"LAAO Versus NOAC in Patients with AF and PCI","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2022-09-01","conditions":"Atrial Fibrillation, Percutaneous Coronary Intervention","enrollment":1386},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT02209350","phase":"PHASE1","title":"Study of the AFB and Stenting of the Iliac Arteries","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-08-02","conditions":"Aorta-iliac Segment Lesion (C,D Type by TASC II)","enrollment":202},{"nctId":"NCT04948749","phase":"NA","title":"Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2021-07-02","conditions":"ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent","enrollment":792},{"nctId":"NCT06742567","phase":"PHASE3","title":"Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction","status":"RECRUITING","sponsor":"National Institute of Cardiovascular Diseases, Pakistan","startDate":"2024-12-02","conditions":"Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis","enrollment":472},{"nctId":"NCT04100135","phase":"NA","title":"GORE® CARDIOFORM Septal Occluder Migraine Clinical Study","status":"TERMINATED","sponsor":"W.L.Gore & Associates","startDate":"2021-02-05","conditions":"Migraine, Patent Foramen Ovale, PFO - Patent Foramen Ovale","enrollment":7},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT02513914","phase":"NA","title":"Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial","status":"SUSPENDED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2020-06-03","conditions":"Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)","enrollment":80},{"nctId":"NCT06591390","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-02-09","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06210646","phase":"PHASE3","title":"Citicoline in Ischemic Stroke, a Randomized Trial","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-12-29","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT06591299","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-04-15","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591351","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591312","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06484647","phase":"","title":"Comparing T-stenting And Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation","status":"RECRUITING","sponsor":"San Luigi Gonzaga Hospital","startDate":"2024-06-01","conditions":"Coronary Artery Disease, Ischemic Heart Disease, Chronic Coronary Syndrome","enrollment":382},{"nctId":"NCT03718559","phase":"PHASE4","title":"Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Gi-Byoung Nam","startDate":"2019-05-14","conditions":"Atrial Fibrillation, Coronary Artery Disease, Stable Angina","enrollment":1040},{"nctId":"NCT06424548","phase":"NA","title":"Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis.","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Seoul Hospital","startDate":"2024-05-16","conditions":"Stroke, Atherosclerosis","enrollment":100},{"nctId":"NCT05141305","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-01-19","conditions":"Ischemic Stroke, Acute","enrollment":516},{"nctId":"NCT04305587","phase":"PHASE1","title":"Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-03-16","conditions":"Diabetes Mellitus Type 2","enrollment":66},{"nctId":"NCT05209412","phase":"NA","title":"Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-02-01","conditions":"De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":370},{"nctId":"NCT06164834","phase":"PHASE1","title":"Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects","status":"UNKNOWN","sponsor":"HK inno.N Corporation","startDate":"2023-12-05","conditions":"Healthy","enrollment":48},{"nctId":"NCT05934799","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2023-06-16","conditions":"Bioequivalence","enrollment":60},{"nctId":"NCT04261478","phase":"NA","title":"Endovascular Acute Stroke Intervention - Tandem OCclusion Trial","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2020-08-31","conditions":"Stroke, Acute, Carotid Stenosis, Carotid Artery Diseases","enrollment":458},{"nctId":"NCT04420351","phase":"PHASE3","title":"Thrombolysis of Urokinase for Minor Stroke","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2020-10-04","conditions":"Minor Stroke","enrollment":1005},{"nctId":"NCT06102720","phase":"PHASE4","title":"Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization","status":"UNKNOWN","sponsor":"Mikhail Zykov","startDate":"2023-01-12","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT05162053","phase":"PHASE1","title":"PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers","status":"COMPLETED","sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","startDate":"2021-12-09","conditions":"Acute Coronary Syndrome","enrollment":128},{"nctId":"NCT02170103","phase":"NA","title":"Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2018-09-16","conditions":"STEMI, Chest Pain","enrollment":50},{"nctId":"NCT06088433","phase":"PHASE4","title":"Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease","status":"UNKNOWN","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-11-15","conditions":"Coronary Heart Disease","enrollment":292},{"nctId":"NCT06021990","phase":"PHASE3","title":"Clopidogrel for the Prevention of Exacerbations in Severe COPD","status":"UNKNOWN","sponsor":"Lady Reading Hospital, Pakistan","startDate":"2023-10-01","conditions":"COPD, COPD Exacerbation Acute","enrollment":162},{"nctId":"NCT05960721","phase":"NA","title":"Low-dose NOAC Versus GDMT After LAAO","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2023-07-06","conditions":"Atrial Fibrillation","enrollment":4220},{"nctId":"NCT03703635","phase":"NA","title":"Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2018-10-17","conditions":"Intracranial Artery Stenosis","enrollment":512},{"nctId":"NCT05902000","phase":"NA","title":"Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion","status":"UNKNOWN","sponsor":"Xueli Cai","startDate":"2023-06-14","conditions":"Thrombectomy, Tandem Occlusion, Stroke","enrollment":222},{"nctId":"NCT05910125","phase":"PHASE4","title":"Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-07","conditions":"Ischemic Stroke","enrollment":472},{"nctId":"NCT03764241","phase":"PHASE3","title":"Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2020-02-01","conditions":"ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus","enrollment":280},{"nctId":"NCT02206815","phase":"PHASE4","title":"Safety of \"Ticagrelor+ Warfarin\"in Comparison With \"Clopidogrel+Aspirin+Warfarin\"","status":"COMPLETED","sponsor":"Genshan Ma","startDate":"2014-09-19","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":296},{"nctId":"NCT05574374","phase":"PHASE1","title":"Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2022-09-21","conditions":"Drug Drug Interaction","enrollment":36},{"nctId":"NCT05770674","phase":"NA","title":"Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES","status":"UNKNOWN","sponsor":"Kiyuk Chang","startDate":"2022-04-01","conditions":"Coronary Artery Disease","enrollment":2186},{"nctId":"NCT05623904","phase":"NA","title":"Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2022-10-14","conditions":"Carotid Artery Stenting, Carotid Endarterectomy, Best Medical Treatment","enrollment":1056},{"nctId":"NCT05546320","phase":"PHASE4","title":"Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2022-10-15","conditions":"Patent Foramen Ovale, Migraine","enrollment":1000},{"nctId":"NCT03649711","phase":"PHASE3","title":"Chronic Kidney Disease (CKD) Platelet Study","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2018-11-01","conditions":"Chronic Kidney Diseases, Heart Attack, Stroke, Ischemic","enrollment":76},{"nctId":"NCT02869009","phase":"PHASE3","title":"Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2016-11","conditions":"Ischemic Stroke","enrollment":3000},{"nctId":"NCT05573958","phase":"PHASE4","title":"To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Sarmad Zahoor","startDate":"2022-10-01","conditions":"Acute Coronary Syndrome","enrollment":90},{"nctId":"NCT03661411","phase":"PHASE4","title":"Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2018-10-17","conditions":"Stroke","enrollment":760},{"nctId":"NCT01121224","phase":"PHASE4","title":"Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-01-11","conditions":"Saphenous Vein Graft Atherosclerosis","enrollment":597},{"nctId":"NCT02835534","phase":"PHASE4","title":"The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI","status":"COMPLETED","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2016-05","conditions":"Acute ST Elevation Myocardial Infarction","enrollment":818},{"nctId":"NCT03198741","phase":"PHASE4","title":"Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2017-07-13","conditions":"Gastrointestinal Injury, Ischemic Heart Disease","enrollment":783},{"nctId":"NCT05238610","phase":"","title":"Prospective Registry of Elderly ESUS With PFO","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2022-01-17","conditions":"Embolic Stroke of Undetermined Source","enrollment":1200},{"nctId":"NCT04078737","phase":"PHASE3","title":"Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2019-09-23","conditions":"Stroke, Transient Ischemic Attack","enrollment":6412},{"nctId":"NCT05125549","phase":"PHASE1","title":"Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2018-07-12","conditions":"Pharmacokinetics","enrollment":48},{"nctId":"NCT03672097","phase":"PHASE4","title":"Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company","startDate":"2018-10-16","conditions":"Acute Coronary Syndrome (ACS)","enrollment":204},{"nctId":"NCT03284827","phase":"PHASE4","title":"Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2018-03-15","conditions":"Aortic Valve Stenosis","enrollment":235},{"nctId":"NCT05063630","phase":"NA","title":"Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke","status":"UNKNOWN","sponsor":"Can Tho Stroke International Services Hospital","startDate":"2019-05-01","conditions":"Intracranial Arteriosclerosis, Ischemic Stroke, Intracranial Arterial Diseases","enrollment":300},{"nctId":"NCT02018055","phase":"PHASE4","title":"TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI","status":"COMPLETED","sponsor":"The Catholic University of Korea","startDate":"2014-02-14","conditions":"Acute Myocardial Infarction","enrollment":2590},{"nctId":"NCT02989558","phase":"PHASE3","title":"A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI","status":"COMPLETED","sponsor":"University of Athens","startDate":"2016-12","conditions":"Aortic Valve Stenosis","enrollment":90},{"nctId":"NCT02843633","phase":"NA","title":"LEADERS FREE II: BioFreedom™ Pivotal Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biosensors Europe SA","startDate":"2017-02-14","conditions":"Acute Coronary Syndrome, High Bleeding Risk","enrollment":1203},{"nctId":"NCT04671069","phase":"PHASE1","title":"Drug Interaction Study of MGL-3196 With Clopidogrel","status":"COMPLETED","sponsor":"Madrigal Pharmaceuticals, Inc.","startDate":"2019-07-26","conditions":"Healthy","enrollment":20},{"nctId":"NCT01743937","phase":"PHASE4","title":"A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2013-01","conditions":"Ischemic Preconditioning","enrollment":18},{"nctId":"NCT00738894","phase":"NA","title":"GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients","status":"COMPLETED","sponsor":"W.L.Gore & Associates","startDate":"2008-12-10","conditions":"Stroke, Transient Ischemic Attack","enrollment":664},{"nctId":"NCT04588571","phase":"NA","title":"Efficacy and Safety Comparison of the Open Surgical and Endovascular Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D.","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2020-10-01","conditions":"Atherosclerosis, Ischemia Limb, Superficial Femoral Artery Occlusion","enrollment":110},{"nctId":"NCT03008083","phase":"PHASE4","title":"Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation","status":"UNKNOWN","sponsor":"Shanghai MicroPort Medical (Group) Co., Ltd.","startDate":"2019-01-10","conditions":"Drug-Eluting Stents, Percutaneous Coronary Intervention","enrollment":2446},{"nctId":"NCT03372785","phase":"","title":"The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2018-04-10","conditions":"Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Coronary Artery Disease","enrollment":240},{"nctId":"NCT02944123","phase":"PHASE3","title":"Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2016-09","conditions":"Acute Coronary Syndrome","enrollment":120},{"nctId":"NCT02506140","phase":"PHASE2, PHASE3","title":"Platelet Reactivity in Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2015-08","conditions":"Stroke, Ischemic Attack, Transient","enrollment":675},{"nctId":"NCT00979589","phase":"PHASE3","title":"Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2009-12","conditions":"Stroke, Transient Ischemic Attack","enrollment":5100},{"nctId":"NCT04171687","phase":"PHASE1","title":"Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2019-10-21","conditions":"Healthy","enrollment":36},{"nctId":"NCT04368377","phase":"PHASE2","title":"Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19","status":"COMPLETED","sponsor":"University of Milan","startDate":"2020-04-06","conditions":"Pneumonia, Viral, Corona Virus Infection, Respiratory Failure","enrollment":5},{"nctId":"NCT01261832","phase":"PHASE4","title":"Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients","status":"UNKNOWN","sponsor":"Korea University Guro Hospital","startDate":"2011-07","conditions":"Acute Myocardial Infarction","enrollment":951},{"nctId":"NCT00687076","phase":"PHASE4","title":"Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2004-04","conditions":"Peripheral Arterial Disease","enrollment":102},{"nctId":"NCT02556203","phase":"PHASE3","title":"Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes","status":"TERMINATED","sponsor":"Bayer","startDate":"2015-12-16","conditions":"Transcatheter Aortic Valve Replacement","enrollment":1653},{"nctId":"NCT02260622","phase":"PHASE2","title":"Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2014-10","conditions":"Critical Limb Ischemia","enrollment":20},{"nctId":"NCT03814642","phase":"PHASE1","title":"Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2019-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT04023630","phase":"PHASE4","title":"DUAL Antithrombotic Therapy in Patients With AF and ACS","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-10-01","conditions":"Atrial Fibrillation, Acute Coronary Syndromes","enrollment":4000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Plavix"],"phase":"marketed","status":"active","brandName":"Patent clopidogrel","genericName":"Patent clopidogrel","companyName":"Hospital Central San Luis Potosi, Mexico","companyId":"hospital-central-san-luis-potosi-mexico","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clopidogrel is a small molecule medication used to treat various conditions, including heart attack, stroke, and ischemic events, as well as chronic kidney disease. It is typically administered at a dose of 75mg.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}